Clinical Trial Update: Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis [Phase 2, Phase 3]

View source ↗

Summary

This update reports results from phase 2 and phase 3 trials evaluating the efficacy of levofloxacin 0.5% ophthalmic solution administered three times daily for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• Levofloxacin 0.5% ophthalmic solution (levofloxacin)

Snippet

Sponsor: Laser Microsurgery Centre, Poland | Conditions: Bacterial Conjunctivitis | Phase 2, Phase 3 | Status: COMPLETED